Human Genome Epidemiology Literature Finder
|
Records 1 - 15 (of 15 Records) |
| Query Trace: Pneumonia and CRP[original query] |
|---|
| CRP gene variation and risk of community-acquired pneumonia. Respirology (Carlton, Vic.) 2010 Jan 15 (1): 160-4. Mukamal Kenneth J, Pai Jennifer K, O'Meara Ellen S, Tracy Russell P, Psaty Bruce M, Kuller Lewis H, Newman Anne B, Yende Sachin, Curhan Gary C, Siscovick David S, Rimm Eric |
| [Evaluation of the mannose-binding lection gene polymorphism on the severity of community acquired pneumonia in adults]. Zhonghua wei zhong bing ji jiu yi xue 2014 Sep 26 (9): 655-60. Liu Xuehua, Zhang Xueru, Li Qing, Tian Zhuom |
| Polymorphism rs2239185 in vitamin D receptor gene is associated with severe community-acquired pneumonia of children in Chinese Han population: a case-control study. European journal of pediatrics 2015 May 174 (5): 621-9. Li Wei, Guo Linying, Li Hongri, Sun Chunrong, Cui Xiaodai, Song Guowei, Wang Jianhua, Zhang |
| Correlation between serum levels of C-reactive protein and infant pneumonia: A meta-analysis. Experimental and therapeutic medicine 2015 Jun 9 (6): 2331-2338. Xiao Xiao, Xue Long, Sheng Hui-Lin, Xiao Zhi-H |
| CRP/IL-6/IL-10 Single-Nucleotide Polymorphisms Correlate with the Susceptibility and Severity of Community-Acquired Pneumonia. Genetic testing and molecular biomarkers 2016 Oct . Chou Shou-Chu, Ko How-Wen, Lin Ying-Ch |
| Research on the correlation between the fibrinogen ? and attack of pediatric pneumonia. European review for medical and pharmacological sciences 2017 Oct 21 (4 Suppl): 100-105. Liu G, Wu H-W, Li Z |
| Comparison of procalcitonin, a potentially new inflammatory biomarker of frailty, to interleukin-6 and C-reactive protein among older Chinese hospitalized patients. Aging clinical and experimental research 2018 5 30 (12): 1459-1464. Yang Ying, Hao Qiukui, Flaherty Joseph H, Cao Li, Zhou Jianghua, Su Li, Shen Yanjiao, Dong Biro |
| Correction to: CRP/IL-6/IL-10 Single-Nucleotide Polymorphisms Correlate with the Susceptibility and Severity of Community-Acquired Pneumonia by Chou S-C, Ko H-W, and Lin Y-C. Genet Test Mol Biomarkers 2016;20:732-740. DOI: 10.1089/gtmb.2016.0156. Genetic testing and molecular biomarkers 2019 4 23 (6): 433. Authors are not available |
| Genetic polymorphisms of rs9313422 G>C and rs41297579 G>A at the promoter of TIM-1 gene contribute to the risk of community-acquired pneumonia in children. Journal of clinical laboratory analysis 2019 Dec e23095. Liu Yang, Xu Hong- |
| Correlation between TICAM1 gene polymorphisms and community-acquired pneumonia in children. Journal of biochemical and molecular toxicology 2020 Apr e22503. Yang Yong, Yang Suiyu, Chen Zongbo, Liu |
| Elevated plasma YKL-40 and risk of infectious disease: a prospective study of 94665 individuals from the general population. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2020 1 26 (10): 1411.e1-1411.e9. Kjaergaard A D, Helby J, Johansen J S, Nordestgaard B G, Bojesen S |
| Dissecting the IL-6 pathway in cardiometabolic disease: A Mendelian randomization study on both IL6 and IL6R. British journal of clinical pharmacology 2021 12 88 (6): 2875-2884. Cupido Arjen J, Asselbergs Folkert W, Natarajan Pradeep, , Ridker Paul M, Hovingh G Kees, Schmidt A Floria |
| Adhesion molecules as diagnostic and severity biomarkers in pediatric community-acquired pneumonia. The clinical respiratory journal 2021 1 15 (5): 522-529. Tan?r Basaranoglu Sevgen, Ozsurekci Yasemin, Aykac Kubra, Iyigun Irem, Satirer Ozlem, Akin Mustafa Senol, Ceyhan Mehm |
| Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: A Mendelian randomisation study. PLoS medicine 2023 1 20 (1): e1004174. Hamilton Fergus W, Thomas Matt, Arnold David, Palmer Tom, Moran Ed, Mentzer Alexander J, Maskell Nick, Baillie Kenneth, Summers Charlotte, Hingorani Aroon, MacGowan Alasdair, Khandaker Golam M, Mitchell Ruth, Davey Smith George, Ghazal Peter, Timpson Nicholas |
| IL6 receptor inhibitors: exploring the therapeutic potential across multiple diseases through drug target Mendelian randomization. Frontiers in immunology 2024 9 15 1452849. Chong Fu, Longquan Wang, Wenjiao C |
- Page last reviewed:Feb 1, 2024
- Content source: